Company intelligence / Profile preview

Gluroo

California, United Statesgluroo.com ↗

Ownership: Private
Development stage: Other

Overview

Gluroo has developed a collaborative diabetes management application that integrates with continuous glucose monitors (CGMs) and insulin pumps to provide real-time data sharing among patients and caregivers. The app supports logging of blood glucose readings, insulin dosing, carbohydrate intake estimation via AI photo analysis, and device integration across multiple platforms. As of June 2025, it is not yet FDA-approved or fully commercially launched but has over 43,000 users in more than 100 countries through early access programs[1][2].

Therapeutic areas: Endocrinology
Modalities: DeviceDigital health platform (app/software)
Industry: Digital Health Medical Devices

Partnerships

Integrates with devices from Dexcom and Omnipod for data sharing; no formal partnerships disclosed as of June 2025

Beyond the preview

Go deeper on Gluroo.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gluroo.

Explore the full profile